Leonardi Darío, Barrera María Gabriela, Lamas María Celina, Salomón Claudio Javier
Departamento Farmacia, Facultad de Cs Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, IQUIOS, CONICET, Suipacha 531, 2000, Rosario, Argentina.
AAPS PharmSciTech. 2007 Dec 14;8(4):E108. doi: 10.1208/pt0804108.
The aim of the current study was to design oral fast-release polymeric tablets of prednisone and to optimize the drug dissolution profile by modifying the carrier concentration. Solid dispersions were prepared by the solvent evaporation method at different drug:polymer ratios (wt/wt). The physical state and drug:carrier interactions were analyzed by X-ray diffraction, infrared spectroscopy, and scanning electron microscopy. The dissolution rate of prednisone from solid dispersions was markedly enhanced by increasing the polymer concentration. The tablets were prepared from solid dispersion systems using polyethylene glycol (PEG) 6000 as a carrier at low and high concentration. The results showed that PEG 6000-based tablets exhibited a significantly higher prednisone dissolution (80% within 30 minutes) than did conventional tablets prepared without PEG 6000 (<25% within 30 minutes). In addition, the good disintegration and very good dissolution performance of the developed tablets without the addition of superdisintegrant highlighted the suitability of these formulated dosage forms. The stability studies performed in normal and accelerated conditions during 12 months showed that prednisone exhibited high stability in PEG 6000 solid dispersion powders and tablets. The X-ray diffraction showed that the degree of crystallinity of prednisone in solid dispersions decreased when the ratio of the polymer increased, suggesting that the drug is present inside the samples in different physical states. The Fourier transform infrared spectroscopic studies showed the stability of prednisone and the absence of well-defined drug:polymer interactions. Scanning electron microscopy images showed a novel morphology of the dispersed systems in comparison with the pure components.
本研究的目的是设计泼尼松口服速释聚合物片,并通过改变载体浓度优化药物溶出曲线。采用溶剂蒸发法,以不同的药物:聚合物比例(重量/重量)制备固体分散体。通过X射线衍射、红外光谱和扫描电子显微镜分析物理状态和药物:载体相互作用。通过增加聚合物浓度,泼尼松从固体分散体中的溶出速率显著提高。使用聚乙二醇(PEG)6000作为载体,在低浓度和高浓度下从固体分散体系制备片剂。结果表明,与未添加PEG 6000制备的传统片剂(30分钟内<25%)相比,基于PEG 6000的片剂表现出显著更高的泼尼松溶出度(30分钟内80%)。此外,所开发的片剂在不添加超级崩解剂的情况下具有良好的崩解性和非常好的溶出性能,突出了这些制剂剂型的适用性。在正常和加速条件下进行的12个月稳定性研究表明,泼尼松在PEG 6000固体分散体粉末和片剂中表现出高稳定性。X射线衍射表明,当聚合物比例增加时,固体分散体中泼尼松的结晶度降低,表明药物以不同的物理状态存在于样品内部。傅里叶变换红外光谱研究表明泼尼松的稳定性以及不存在明确的药物:聚合物相互作用。扫描电子显微镜图像显示与纯组分相比,分散体系具有新颖的形态。